Intelligence / Services / Auditor Changes / Regenerex Pharma, INC.
Regenerex Pharma, INC.
16 Nov 2026: Changed auditor (SEC 8-K) · Rosenfield and Company PLLC. Recorded in the SEC EDGAR full-text search.
- Filed
- 16 Nov 2026
- Sector
- Pharma and biotech
- Sic
- 2834
- Items
- 4.01
- Location
- Las Vegas, NV
- State
- Nevada
- Country
- United States
- SEC CIK
- 1357878
- Reference
- 0001472375-26-000229
- Engaged
- Rosenfield and Company PLLC
- Event
- Auditor changed
- Summary
- On October 28, 2026, the Company's Board of Directors finalized the approval of the appointment of Rosenfield and Company PLLC CPA of Corinth, Texas, as the Company's independent registered public accounting firm, as per the engagement letter effective October 26, 2026.
A new auditor brings a new audit plan: controls, accounting advisory, tax and finance-systems work are re-tendered; a resignation often signals reporting problems that need fixing fast.
- Auditor dismissed leads with 57 of 94, then Auditor resigned or declined to stand (25).
- 22 added in the 30 days to 19 Nov 2026.
Find the decision makers at Regenerex Pharma, INC.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this audit signal, for your approval.
Across AOS Research
Other records for Regenerex Pharma, INC. in our registers.
More in Auditor changed
Auditor Changes
Source: SEC EDGAR full-text search, data to 19 Nov 2026. Every Form 8-K reporting Item 4.01 (change in the registrant's certifying accountant) filed with the SEC in the last 90 days. Outgoing and incoming firms are read from the filing's wording; amendments and exhibit letters are not counted. AOS shows what the public record says; it does not verify or endorse the company.